Merit Medical Systems Inc banner

Merit Medical Systems Inc
NASDAQ:MMSI

Watchlist Manager
Merit Medical Systems Inc Logo
Merit Medical Systems Inc
NASDAQ:MMSI
Watchlist
Price: 69.79 USD -1.61% Market Closed
Market Cap: $4.1B

EV/EBITDA

14
Current
34%
Cheaper
vs 3-y average of 21.4

Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBITDA
14
=
Enterprise Value
$4.3B
/
EBITDA
$316.1m

Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBITDA
14
=
Enterprise Value
$4.3B
/
EBITDA
$316.1m

Valuation Scenarios

Merit Medical Systems Inc is trading below its 3-year average

If EV/EBITDA returns to its 3-Year Average (21.4), the stock would be worth $106.31 (52% upside from current price).

Statistics
Positive Scenarios
3/4
Maximum Downside
-8%
Maximum Upside
+62%
Average Upside
27%
Scenario EV/EBITDA Value Implied Price Upside/Downside
Current Multiple 14 $69.79
0%
3-Year Average 21.4 $106.31
+52%
5-Year Average 22.7 $112.95
+62%
Industry Average 12.9 $64.09
-8%
Country Average 14.4 $71.4
+2%

Forward EV/EBITDA
Today’s price vs future ebitda

Today's Enterprise Value EBITDA Forward EV/EBITDA
$4.3B
/
Jan 2026
$316.1m
=
14
Current
$4.3B
/
Dec 2026
$406.6m
=
10.6
Forward
$4.3B
/
Dec 2027
$435.3m
=
9.9
Forward
$4.3B
/
Dec 2028
$469.6m
=
9.2
Forward

Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.

Peer Comparison

All Multiples
EV/EBITDA
P/E
All Countries
Close
Market Cap EV/EBITDA P/E
US
Merit Medical Systems Inc
NASDAQ:MMSI
4.1B USD 14 32.3
US
Medline Inc
NASDAQ:MDLN
63.4B USD 0 0
JP
Hoya Corp
TSE:7741
9.8T JPY 28.4 39.1
CH
Alcon AG
SIX:ALC
30.5B CHF 14.9 38.9
DK
Coloplast A/S
CSE:COLO B
98.2B DKK 13 24.6
US
Align Technology Inc
NASDAQ:ALGN
13.7B USD 14.5 33.3
UK
ConvaTec Group PLC
LSE:CTEC
4.6B GBP 12.1 34.9
CA
Bausch + Lomb Corp
NYSE:BLCO
5.9B USD 17.4 -16.4
KR
HLB Inc
KOSDAQ:028300
8.4T KRW -84.9 -38
JP
Asahi Intecc Co Ltd
TSE:7747
895.2B JPY 23.9 50.6
US
Lantheus Holdings Inc
NASDAQ:LNTH
5.4B USD 14.9 23.2
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Merit Medical Systems Inc
NASDAQ:MMSI
Average EV/EBITDA: 17
14
14%
1
US
M
Medline Inc
NASDAQ:MDLN
Not Available
9%
N/A
JP
Hoya Corp
TSE:7741
28.4
13%
2.2
CH
Alcon AG
SIX:ALC
14.9
9%
1.7
DK
Coloplast A/S
CSE:COLO B
13
6%
2.2
US
Align Technology Inc
NASDAQ:ALGN
14.5
14%
1
UK
ConvaTec Group PLC
LSE:CTEC
12.1
11%
1.1
CA
Bausch + Lomb Corp
NYSE:BLCO
17.4
29%
0.6
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -84.9 N/A N/A
JP
A
Asahi Intecc Co Ltd
TSE:7747
23.9
13%
1.8
US
Lantheus Holdings Inc
NASDAQ:LNTH
14.9
23%
0.6
P/E Multiple
Earnings Growth PEG
US
Merit Medical Systems Inc
NASDAQ:MMSI
Average P/E: 34.6
32.3
30%
1.1
US
M
Medline Inc
NASDAQ:MDLN
Not Available
30%
N/A
JP
Hoya Corp
TSE:7741
39.1
15%
2.6
CH
Alcon AG
SIX:ALC
38.9
32%
1.2
DK
Coloplast A/S
CSE:COLO B
24.6
21%
1.2
US
Align Technology Inc
NASDAQ:ALGN
33.3
34%
1
UK
ConvaTec Group PLC
LSE:CTEC
34.9
41%
0.9
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -16.4 N/A N/A
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -38 N/A N/A
JP
A
Asahi Intecc Co Ltd
TSE:7747
50.6
40%
1.3
US
Lantheus Holdings Inc
NASDAQ:LNTH
23.2
30%
0.8

Market Distribution

In line with most companies in the United States of America
Percentile
49th
Based on 9 875 companies
49th percentile
14
Low
0 — 10
Typical Range
10 — 21.5
High
21.5 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 10
Median 14.4
70th Percentile 21.5
Max 1 767 274.1

Merit Medical Systems Inc
Glance View

Merit Medical Systems Inc. stands as a hallmark of innovation and precision in the medical device industry. Founded in 1987, this Utah-based company has carved a niche by developing and manufacturing a diverse range of products designed to enhance the ability of physicians and improve patient care. Merit's operations focus on the production of disposable medical devices catering primarily to the fields of interventional cardiology, radiology, endoscopy, and pain management. These products, which include a variety of catheters, microcatheters, embolization coils, and other technical components, are crucial in facilitating minimally invasive procedures that speak to the modern medical demand for efficiency and reduced patient recovery times. The company's relentless pursuit of quality and innovation has spurred consistent growth and expanded its presence globally, illustrating its commitment to meeting the evolving needs of healthcare providers and their patients. Revenue streams for Merit Medical Systems derive primarily from the sales of these specialized medical devices, accompanied by an expanding portfolio of customer-driven services and support. Unlike many companies that might get mired in a single product line, Merit has strategically diversified its offerings to spread risk and capture a broader segment of the healthcare market. This diversification is reflected in their investment in research and development, enabling the launch of new products regularly, thereby cushioning the company against the volatility typically seen in the medical device sector. The company’s success is a testament to its ability to maintain close relationships with healthcare providers, listening to and fulfilling their complex needs while operating through an intricate web of direct sales representatives and distribution partners globally. This cohesive model fosters both customer loyalty and drives sustainable business growth, ensuring that Merit Medical Systems remains a pivotal player in the evolving landscape of medical technology.

MMSI Intrinsic Value
79.59 USD
Undervaluation 12%
Intrinsic Value
Price $69.79
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett